Idiazole 20mg DR tabs

DRUG3 trials

Sponsors

GlaxoSmithKline, Genuine Research Center, Egypt

Conditions

Gastrointestinal DiseasesHealthy

Phase 1

A Bioequivalence Study of Rabeprazole From Idiazole 20mg DR Tabs (GSK, Egypt) and PARIET 20 mg DR Tabs (JANSSEN, EGYPT)

CompletedNCT02477306

Genuine Research Center, EgyptHealthy

Start: 2014-03-31End: 2014-03-31Updated: 2015-06-22

Phase 4

A Bioequivalence Study of Idiazole 20mg DR Tabs and PARIET® 20 mg DR Tabs After a Single Oral Dose Administration Under Fasting Conditions in Healthy Adults

CompletedNCT02446483

GlaxoSmithKlineGastrointestinal Diseases

Start: 2014-03-19End: 2014-03-26Updated: 2017-11-17

Bioequivalence Study of Raperazole 20mg DR Tabs and PARIET® 20 mg DR Tabs Under Fed Conditions

CompletedNCT02605395

GlaxoSmithKlineGastrointestinal Diseases

Start: 2014-03-22End: 2014-03-30Updated: 2018-10-01